A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial.
- DOI
- 10.1016/s0140-6736(17)33103-3
- Published
- 2018 Feb 3
- Container
- Lancet (London, England)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s0140-6736-17-33103-3,
title = {A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial.},
author = {de Winter RJ and Katagiri Y and Asano T and Milewski KP and Lurz P and Buszman P and Jessurun GAJ and Koch KT and Troquay RPT and Hamer BJB and Ophuis TO and Wöhrle J and Wyderka R and Cayla G and Hofma SH and Levesque S and Żurakowski A and Fischer D and Kośmider M and Goube P and Arkenbout EK and Noutsias M and Ferrari MW and Onuma Y and Wijns W and Serruys PW},
year = {2018},
journal = {Lancet (London, England)},
doi = {10.1016/s0140-6736(17)33103-3},
url = {https://doi.org/10.1016/s0140-6736(17)33103-3}
}RIS
TY - JOUR TI - A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial. AU - de Winter RJ AU - Katagiri Y AU - Asano T AU - Milewski KP AU - Lurz P AU - Buszman P AU - Jessurun GAJ AU - Koch KT AU - Troquay RPT AU - Hamer BJB AU - Ophuis TO AU - Wöhrle J AU - Wyderka R AU - Cayla G AU - Hofma SH AU - Levesque S AU - Żurakowski A AU - Fischer D AU - Kośmider M AU - Goube P AU - Arkenbout EK AU - Noutsias M AU - Ferrari MW AU - Onuma Y AU - Wijns W AU - Serruys PW PY - 2018 JO - Lancet (London, England) DO - 10.1016/s0140-6736(17)33103-3 UR - https://doi.org/10.1016/s0140-6736(17)33103-3 ER -
APA
RJ, D. W., Y, K., T, A., KP, M., P, L., P, B., GAJ, J., KT, K., RPT, T., BJB, H., TO, O., J, W., R, W., G, C., SH, H., S, L., A, Ż., D, F., M, K., P, G., EK, A., M, N., MW, F., Y, O., W, W., & PW, S. (2018). A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(17)33103-3
Source records
- pubmed · retrieved 2026-09-25T15:02:45.849Z